Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology Case Report: Hand Abnormalities Feature of Fetal Hydantoin Syndrome

Reshma Khan, MD, & Andrew Evans, DO  |  Issue: November 2017  |  November 6, 2017

Discussion

This case report illustrates the musculoskeletal anomalies seen in fetal hydantoin syndrome. Hypoplastic distal phalanges and fingernails are common features. In this case, the patient did not represent the full picture of the syndrome.

The full syndrome can include hypoplastic distal phalanges with small fingernails, a digital-type thumb, abnormal palmar creases, increased frequency of low arch, digital dermal ridge patterns and hip dislocation. Our patient had only hypoplastic distal phalanges, small fingernails and a thinner-than-normal thumb, described as a digital-type thumb.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A case was reported in the orthopedic literature showing hip dysplasia discovered in a 23-year-old male with hypoplasia of fingernails and distal tapering of fingers due to fetal hydantoin syndrome.6 However, the same patient also had mild mental retardation, which fortunately was not the case in our patient.

Fetal hydantoin syndrome affects males and females in equal numbers. The exact incidence and prevalence of the disorder are unknown. Various studies have suggested an approximate incident rate of 5–10% of fetal hydantoin syndrome in infants exposed to phenytoin in utero.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

No diagnostic testing can identify fetal hydantoin syndrome. A diagnosis is made clinically based upon identification of characteristic symptoms in an affected infant in conjunction with a history of phenytoin exposure during gestation.

It has been also noted that the majority of infants born to women who take pheny­toin during pregnancy will not develop fetal hydantoin syndrome. It is not clear whether the adverse effects of phenytoin during fetal development are due to the drug itself or if they are caused by one of phenytoin’s metabolites. The potential role of other factors, such as genetic influences that affect phenytoin metabolism or additional environmental factors (e.g., smoking), remains unclear. There have been reports in the medical literature that women with mutations in the methylenetetrahydrofolate reductase (MTHFR) gene are at an increased risk of having an infant with fetal hydantoin syndrome.

Evidence is accumulating from clinical reports and animal experiments to support the notion that mild distal digital hypoplasia is a relatively specific marker for in utero exposure to the drug. More severe digital involvement has also been identified, although to a lesser extent, in animal experiments and in only a few humans exposed to the drug in utero.

Apart from digital involvement, an association between in utero exposure to diphenyl-hydantoin and more proximal (carpal metacarpal) anomalies has yet not been reported.7 The frequent finding of low arch dermal ridge patterning on affected fingertips indicates that the fetal fingertip pads were hypoplastic by 15–20 weeks of fetal life, the age when dermal ridge development and patterning is established. The severity of defects varies from the more common mild hypoplasia of nails and distal phalanges, as in our patient, to the more unusual gross deficiency of whole digits, as reported in some cases.8

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsResearch Rheum Tagged with:anticonvulsive drugcase reportClinicaldistal limb deformityEpilepsyfetal hydnatoin syndromegenetic anomolyhand abnormalityMedicationoutcomepathologyResearchRheumatic Diseaserheumatologyrisk

Related Articles
    Oksana Shufrych TKTK / Shutterstock.com

    Heated Gloves May Improve Hand Function in Diffuse Systemic Sclerosis

    October 16, 2017

    Systemic sclerosis (SSc), a subtype of scleroderma, is a rare, complex autoimmune disease characterized by widespread vasculopathy of the small arteries and fibroblast dysfunction.1,2 It has been described as a fibrosing micro­vascular disease, because vascular injury precedes and leads to tissue fibrosis.3 The resulting Raynaud’s phenomenon, pain, skin thickening and tightening, and multi-organ involvement have…

    Case Report: Drug-Induced Lupus

    September 14, 2021

    The incidence of drug-induced lupus continues to rise as clinicians expand their therapeutic armamentarium. An estimated 15,000–30,000 cases of drug-induced lupus occur every year in the U.S. alone.1 It is a well-known, but rare, complication of commonly used medications, such as anti-hypertensive, anti-arrhythmic and anti-epileptic drugs, as well as biologic and immune checkpoint therapies.2,3 The…

    Brandon Crawford / shutterstock.com

    Case Report: Blunt Smoker Denies Tobacco Use, Delaying Diagnosis

    May 12, 2022

    Cannabis arteritis mirrors thrombo­angiitis obliterans in its clinical and arteriographic presentation, but its relevant exposure is cannabis rather than tobacco.1 Whether cannabis arteritis is a subset of thromboangiitis obliterans or a unique pathologic entity is debatable. Delta-9-tetrahydrocannabinol, the primary psychoactive component of cannabis, is a peripheral vasoconstrictor.2 This offers mechanistic insight into how cannabis may…

    Case Report: A Patient Presents with Digital Ischemia & Gangrene

    June 10, 2023

    Defined by the presence of antiphospholipid antibodies (aPL) in individuals with clinical evidence of thrombosis or pregnancy morbidity, antiphospholipid syndrome (APS) is a systemic autoimmune thrombophilia. Clinical thrombosis, which should be confirmed by objective validated criteria (e.g., imaging studies or histopathology), can occur in the arterial, venous or small vessel vasculature and is not limited…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences